Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise


Women's Health

Developing and commercializing therapies for women’s menopausal health concerns has been a cornerstone of Noven’s business since it was founded in 1987. In this area, Noven developed the first FDA-approved adhesive matrix estrogen therapy patch, the first approved combination (two-drug) patch, Combipatch® (estradiol/norethindrone acetate transdermal system), the planet’s smallest estrogen patch, Minivelle® (estradiol transdermal system) and Brisdelle® (paroxetine 7.5 mg capsules), the first and only FDA-approved, non-hormonal treatment for moderate to severe hot flashes. Noven also manufactures hormone therapy patches that are marketed and sold by partners around the world.

Brisdelle Logo Minivelle Logo CombiPatch Logo

More Information

Brisdelle®, Minivelle®
and CombiPatch®
Patient, Physician
and Pharmacist Inquiries:

Tel: 800-455-8070